Valuation: Bonesupport Holding AB

Market Cap 2.09TCr 211.11Cr 188.43Cr 173.84Cr 157.94Cr 296.29Cr 20TCr 300.85Cr 824.96Cr 10TCr 792.41Cr 775.44Cr 33TCr P/E 2026 *
65.8x
P/E 2027 * 41.4x
Enterprise Value 2.04TCr 205.99Cr 183.86Cr 169.62Cr 154.11Cr 289.11Cr 20TCr 293.55Cr 804.95Cr 10TCr 773.19Cr 756.63Cr 32TCr EV / Sales 2026 *
13.5x
EV / Sales 2027 * 10x
Free-Float
89.54%
Yield 2026 *
0.47%
Yield 2027 * 0.69%
1 day+1.72%
1 week+27.91%
Current month+42.18%
1 month+51.50%
3 months+60.36%
6 months+32.41%
Current year+72.13%
1 week 246
Extreme 246
331
1 month 210.4
Extreme 210.4
331
Current year 165
Extreme 165
331
1 year 165
Extreme 165
331
3 years 112.7
Extreme 112.7
405.8
5 years 34.2
Extreme 34.2
405.8
10 years 9.04
Extreme 9.04
405.8
Manager TitleAgeSince
Chief Executive Officer 49 01/09/2025
Director of Finance/CFO 63 01/11/2018
Chief Operating Officer 51 01/12/2021
Director TitleAgeSince
Director/Board Member 68 01/01/2010
Chairman 70 15/12/2016
Chairman 71 14/05/2019
Date Insider Type Main position Quantity % Market Cap. Importance
28/08/26 Buy

Public Communications Manager

170 0.0003%
26/08/26 Buy

Director

30 0.0000%
20/07/26 Buy

Chief Executive Officer

1,950 0.0030%
Change 5-day change 1-year change 3-year change Capi.($)
+1.72%+27.91%+35.74%+182.87% 211.11Cr
+2.83%+4.40%+60.84%+123.50% 1,16500Cr
+3.81%+5.66%+38.70%+74.91% 64TCr
+0.14%+0.63%+24.71%+95.03% 50TCr
-0.34%+3.03%+43.85%+64.47% 38TCr
-1.76%+1.41%+68.06%+43.41% 36TCr
-0.69%+2.57%+22.37%+51.36% 30TCr
-1.86%+2.38%+1.97%+26.16% 27TCr
+2.04%+3.05%+51.12%+60.42% 24TCr
+2.36%-0.11%+29.42%+102.04% 19TCr
Average +0.00%+4.77%+37.68%+82.42% 40.58TCr
Weighted average by Cap. -0.42%+3.18%+43.07%+83.11%

Financials

2026 *2027 *
Net sales 150.84Cr 15Cr 14Cr 13Cr 11Cr 21Cr 1.44TCr 22Cr 59Cr 754.58Cr 57Cr 56Cr 2.39TCr 201.33Cr 20Cr 18Cr 17Cr 15Cr 28Cr 1.92TCr 29Cr 79Cr 1.01TCr 76Cr 75Cr 3.19TCr
Net income 32Cr 3.26Cr 2.91Cr 2.68Cr 2.44Cr 4.58Cr 308.83Cr 4.65Cr 13Cr 161.8Cr 12Cr 12Cr 512.57Cr 52Cr 5.21Cr 4.65Cr 4.29Cr 3.9Cr 7.32Cr 493.96Cr 7.43Cr 20Cr 258.79Cr 20Cr 19Cr 819.84Cr
Net Debt -51Cr -5.12Cr -4.57Cr -4.22Cr -3.83Cr -7.19Cr -484.99Cr -7.3Cr -20Cr -254.09Cr -19Cr -19Cr -804.95Cr -85Cr -8.62Cr -7.69Cr -7.1Cr -6.45Cr -12Cr -816.27Cr -12Cr -34Cr -427.66Cr -32Cr -32Cr -1.35TCr
Projected Income Statement - Annual - Bonesupport Holding AB
Logo Bonesupport Holding AB
Bonesupport Holding AB is a Sweden-based orthobiologics company. It develops and commercialize injectable bioceramic bone graft substitutes which remodel to host bone and have the capability to elute drugs directly into the bone void. The marketed synthetic bone graft substitutes are CERAMENT BVF, CERAMENT G and CERAMENT V, which are based on the CERAMENT technology platform. The products are commercially available in Europe and the United States, as well as in India, Malaysia, Oman and Singapore. The products are developed to treat patients with fractures and bone voids caused by trauma and related surgery, as well as caused by infection or diseases, such as chronic osteomyelitis, revision arthroplasty and infected diabetic foot.
Employees
171
Date Price Change Volume
23/26/23 SEK 323.60 +1.19% 6,15,493
22/26/22 SEK 319.80 +24.34% 24,89,567
21/26/21 SEK 257.20 +1.26% 4,26,407
20/26/20 SEK 254.00 +1.44% 3,82,829
19/26/19 SEK 250.40 -1.03% 2,99,631
Trader
Investor
Global
Quality
ESG MSCI
BBB
MarketScreener Ratings - Bonesupport Holding AB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
5
Last Close Price
319.80SEK
Average target price
357.42SEK
Spread / Average Target
+11.76%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Bonesupport Holding AB
  1. Stock Market
  2. Stocks
  3. BONEX Stock